Higher Pride Predicts Slightly Higher Insomnia for Population

Higher Pride Predicts Slightly Higher Insomnia for Population

Contents

Variables

A
Pride 999
A
Insomnia 143

Categories

A
Emotions 2028
A
Symptoms 13336

Tags

Low Confidence
Very Weak Effect Size
Positive Relationship
Population Study
cause image gauge image effect image
Participants reported a 141.7% average increase in Insomnia following above average Pride.

Abstract

Insomnia was generally 0.3% higher than average after 3.5 out of 5 of Pride per 24 hours.

Aggregated data from 1 study participants suggests with a LOW degree of confidence (p=0.194, 95% CI -0.187 to 0.473) that Pride has a weakly positive predictive relationship (R=0.143) with Insomnia.

The highest quartile of Insomnia measurements were observed following an average 3.93 out of 5 Pride.

The lowest quartile of Insomnia measurements were observed following an average 3.5 out of 5 of Pride.

After an onset delay of 0 seconds, Insomnia is typically 67% lower than average over the 24 hours following around 3.5 out of 5 of Pride Pride.

Keywords: Pride, Insomnia, N-of-1 trials, real-world evidence, causal inference, observational study

Preliminary: Based on 1 participants. Results may change as more data is collected.

Results

Primary Findings

Analysis of 34 paired observations from 1 participants revealed a minimal improvement in Insomnia following above-average Pride exposure.

+0.3%
Change from Baseline
Minimal effect on Insomnia
0.00
Predictor Impact Score
Insufficient evidence for causal relationship

Supporting Statistics

Low
Confidence
0.143
Correlation (r)
p = 0.199
Significance
z = 0.28
Effect Magnitude
φ = 1.00
Temporality

What This Means

When participants had above-average Pride:

  • Insomnia increased by 0.3% on average
  • Temporal analysis supports Pride as the predictor (not the outcome)

Interpreting the Predictor Impact Score

The Predictor Impact Score (PIS) integrates multiple Bradford Hill causal criteria into a single metric. Use this guide to interpret the score:

PIS Range Interpretation Recommended Action
≥ 0.5 Strong evidence High priority for RCT validation
0.3 - 0.5 Moderate evidence Consider for experimental investigation
0.1 - 0.3 Weak evidence Monitor for additional data
< 0.1 Insufficient evidence Low priority; may be noise

Note: PIS is a prioritization heuristic, not proof of causation. High scores indicate relationships worth investigating, not confirmed causal effects. With only 1 participants, these scores are preliminary and will become more reliable as additional data is collected.

Optimal Daily Values (Precision Dosing)

Based on the observed relationship, we can estimate the predictor values associated with the best and worst outcomes. These values enable personalized dosing recommendations.

⚠️ Preliminary Data: With 1 participants and 34 observations, these optimal values are preliminary estimates. As more data is collected, precision will improve significantly.

4.0 /5
Value Predicting Higher Insomnia
Average Pride when Insomnia exceeded its mean
3.5 /5
Value Predicting Lower Insomnia
Average Pride when Insomnia was below its mean

What This Suggests

Insomnia tended to be highest when Pride was around 4.0 /5.

Important: These values reflect correlations, not guaranteed causal effects. Individual responses may vary. Use as a starting point for personal experimentation, not as a definitive prescription. Consult healthcare providers before making treatment decisions.

Population Correlation

Pride Distribution

Insomnia Distribution

Statistical Summary

Relationship Statistics

Property Value
Cause Variable Name Pride
Effect Variable Name Insomnia
Sinn Predictive Coefficient 0.0013608249856137
Confidence Level LOW
Confidence Interval 0.3304
Forward Pearson Predictive Coefficient 0.143
Critical T Value 1.684
Average Pride Over Previous 24 hours Before ABOVE Average Insomnia 3.93 out of 5
Average Pride Over Previous 24 hours Before BELOW Average Insomnia 3.5 out of 5
Duration of Action 24 hours
Effect Size weakly positive
Number of Paired Measurements 34
Optimal Pearson Product 0.079812192309238
P Value 0.19436
Statistical Significance 0.1986
Strength of Relationship 0.3304
Study Type population
Analysis Performed At 2026-01-04
Number of Participants 1

Pride Info

Property Value
Variable Name Pride
Aggregation Method MEAN
Analysis Performed At 2021-01-25
Duration of Action 24 hours
Kurtosis 2.1323643437355
Maximum Allowed Value 5 out of 5
Mean 2.2469480289622 out of 5
Median 2.2071096540628 out of 5
Minimum Allowed Value 1 out of 5
Number of Aggregate Predictors 895
Number of Aggregate Outcomes 104
Number of Measurements 21462
Number of Measurements (including those generated by tagged, joined, or child variables) 21462
Public true
Onset Delay 0 seconds
Standard Deviation 0.50383781711499
Unit 1 to 5 Rating
User Variables 1270
UPC 0
Variable Category Emotions
Variable ID 1411
Variance 0.56713188699026

Insomnia Info

Property Value
Variable Name Insomnia (h)
Aggregation Method MEAN
Analysis Performed At 2020-10-12
Duration of Action 24 hours
Filling Value 0
Kurtosis 18.732328052844
Maximum Allowed Value 7 days
Mean 102 minutes
Median 43 minutes
Minimum Allowed Value 0 seconds
Number of Aggregate Predictors 109
Number of Aggregate Outcomes 34
Number of Measurements 35
Number of Measurements (including those generated by tagged, joined, or child variables) 32
Public true
Onset Delay 0 seconds
Standard Deviation 1.2938450787413
Unit Hours
User Variables 8
UPC 0
Variable Category Symptoms
Variable ID 1462811
Variance 4.3115868386152

Introduction

Background

Pride (Emotions) and Insomnia (Symptoms) are both important factors in understanding human health and well-being. This study investigates the relationship between these two variables using real-world observational data.

Traditional randomized controlled trials (RCTs), while the gold standard for causal inference, are often impractical, expensive, or unethical for studying many health relationships. Aggregated N-of-1 observational studies offer a complementary approach that leverages within-subject comparisons across large populations to identify meaningful patterns.

Research Question

Does Pride affect Insomnia?

Additionally, we seek to determine:

  1. What is the direction and magnitude of any effect?
  2. How confident can we be in this relationship based on the available data?
  3. What are the optimal levels of Pride for maximizing Insomnia?

Study Objective

The objective of this study is to determine the nature of the relationship (if any) between Pride and Insomnia. Additionally, we attempt to determine the Pride values most likely to produce optimal Insomnia values.

Study Overview

This is a population-level observational study using aggregated N-of-1 methodology. By aggregating individual N-of-1 experiments, we can identify population-level patterns while accounting for the substantial individual variation that exists in most health relationships. Effect sizes are reported as percent change from baseline, enabling intuitive interpretation and comparison across different measures.

Full Methodology: Framework for Real-World Evidence-Based Pharmacovigilance: Aggregated N-of-1 Trials for Quantifying Treatment Effects

Discussion

Interpretation of Findings

Participants experienced a 0.3% improvement in Insomnia following above-average Pride exposure. The Predictor Impact Score (PIS) of 0.00 indicates insufficient evidence for a causal relationship.

Statistical Significance

Using a two-tailed t-test with alpha = 0.05, it was determined that the change in Insomnia is not statistically significant at a 95% confidence interval. This suggests that the Pride value may not have a significant influence on the Insomnia value, or that more data is needed to detect an effect.

After treatment, a 142% increase (18 minutes) from the mean baseline 0 seconds was observed. The relative standard deviation at baseline was 1.1%. The observed change was 0.28467 times the standard deviation.

A common rule of thumb considers a change greater than twice the baseline standard deviation on two separate pre-post experiments may be considered significant. This occurrence would have only a 5% likelihood of resulting from random fluctuation (a p-value < 0.05).

T-Test Details
Observed t-value: 1.199
Critical t-value: 1.684

Since t = 1.20 < 1.68, we cannot reject the null hypothesis.

Biological Plausibility

A plausible bio-chemical mechanism between predictor and outcome is critical for interpreting observational findings. This is where human judgment excels beyond statistical analysis.

Community feedback on the biological plausibility of this relationship is still being collected. Consider the known mechanisms by which Pride might influence Insomnia.

Bradford Hill Criteria Assessment

The Bradford Hill criteria provide a framework for assessing causality in observational studies. Our methodology operationalizes six of the nine criteria through the Predictor Impact Score (PIS):

Criterion How Addressed Metric
Strength Effect size magnitude Percent change from baseline (Δ%), z-score
Consistency Cross-participant replication Number of users (N), number of pairs (n)
Temporality Predictor precedes outcome Temporality factor (φ), onset delay (δ > 0)
Biological Gradient Dose-response relationship Gradient coefficient (φgradient)
Plausibility Biological mechanism assessment Community votes on mechanism plausibility
Specificity Category appropriateness Interest factor (finterest)

Predictor Impact Score (PIS)

The PIS integrates multiple Bradford Hill criteria into a composite metric quantifying how reliably a predictor affects an outcome. Higher scores indicate stronger evidence:

Population-Level PIS:

$$\text{PIS}_{\text{agg}} = |r_{\text{forward}}| \cdot w \cdot \phi_{\text{users}} \cdot \phi_{\text{pairs}} \cdot \phi_{\text{change}} \cdot \phi_{\text{gradient}}$$

Where φ-factors are saturation functions approaching 1 as evidence accumulates:

  • φusers = 1 - e-N/10 (user saturation)
  • φpairs = 1 - e-n/nsig (pair saturation)
  • φchange = 1 - e-Δspread/Δsig (effect spread saturation)
  • w = weighted average of plausibility votes

Temporality Assessment

We assess evidence for correct causal direction using the temporality factor:

$$\phi_{\text{temporal}} = \frac{|r_{\text{forward}}|}{|r_{\text{forward}}| + |r_{\text{reverse}}|}$$

Values approaching 1 indicate the predictor precedes the outcome (supporting causation); values near 0.5 suggest ambiguous directionality; values near 0 suggest reverse causation or confounding by indication.

Limitations

As with any observational study, correlation does not prove causation. Key limitations include:

  • Unmeasured confounders: Variables not tracked may influence results
  • Self-selection bias: Health trackers may differ from the general population
  • Measurement error: Self-reported data may contain recall bias
  • Confounding by indication: Sicker individuals may use more treatments

However, within-subject comparison and temporal precedence analysis partially mitigate these limitations. If the relationship is merely coincidental, as participants independently modify their Pride values, the observed strength will decline over time. Spurious correlations naturally dissipate as more data is collected.

Future Directions

Future research should examine:

  • Subgroup analyses to identify individual differences in response
  • Potential confounders and mediators of the observed relationship
  • Optimal dosing and timing for Pride
  • Confirmation through prospective or randomized designs
  • Biological mechanisms underlying the observed effects

Conclusion

📊 Preliminary Findings: With 1 participants, these results are based on limited data. Effect sizes and confidence will improve as more participants contribute data. Consider these findings directional rather than definitive.

Above-average Pride was associated with a 0.3% improvement in Insomnia—a minimal effect. The Predictor Impact Score of 0.00 indicates this relationship is requiring additional data before conclusions.

Bottom Line: Based on a PIS of 0.00 and a 0.3% effect size, this relationship currently lacks sufficient evidence. Continue monitoring as more data becomes available. Note: These conclusions may strengthen or change direction as more data is collected.

These findings contribute to our understanding of how Pride may influence Insomnia in real-world conditions. While preliminary, these results may inform future research directions. As more participants contribute data, the reliability and precision of these findings will improve substantially.

Help End Unnecessary Suffering

Current clinical trials are 82x more expensive than necessary and take 17 years to bring treatments to market. Pragmatic trials integrated into standard healthcare could reduce costs from $41,000 to $500 per participant and compress timelines to just 2 years. Learn how redirecting just 1% of global military spending could accelerate cures for the 2 billion people suffering from treatable diseases.

Make Suffering Optional

Methods

Study Design

This study is based on data donated by 1 participants. Thus, the study design is equivalent to the aggregation of 1 separate n=1 observational natural experiments.

This within-subject design is powerful because it controls for all stable individual characteristics (genetics, baseline health status, socioeconomic factors) that might otherwise confound the relationship between variables.

Data Analysis

Temporal Assumptions

The analysis incorporates temporal assumptions about the relationship between variables:

  • Onset Delay: It was assumed that 0 seconds would pass before a change in Pride would produce an observable change in Insomnia.
  • Duration of Action: It was assumed that Pride could produce an observable change in Insomnia for as much as 24 hours after the stimulus event.

Statistical Methods

For each participant, we calculated the Pearson correlation coefficient between Pride values and subsequent Insomnia values. Individual correlations were then aggregated using Fisher's z-transformation to produce a population-level estimate:

Individual Correlation:

$$r_i = \frac{\sum(x_{ij} - \bar{x}_i)(y_{ij} - \bar{y}_i)}{\sqrt{\sum(x_{ij} - \bar{x}_i)^2 \sum(y_{ij} - \bar{y}_i)^2}}$$

Fisher's Z-Transformation:

$$z_i = \frac{1}{2} \ln\left(\frac{1 + r_i}{1 - r_i}\right)$$

Aggregated Correlation:

$$\bar{r} = \tanh(\bar{z}) \quad \text{where} \quad \bar{z} = \frac{1}{N}\sum_{i=1}^{N} z_i$$

Effect Size Calculation

Effect sizes are reported as percent change from baseline. For each participant, we compare the outcome following above-average predictor values to the overall baseline outcome:

$$\Delta\%_{\text{baseline}} = \frac{\bar{O}_{\text{follow-up}} - \bar{O}_{\text{baseline}}}{\bar{O}_{\text{baseline}}} \times 100$$

Effect Magnitude (Z-Score)

To assess effect magnitude relative to natural variability, we calculate the z-score:

$$z = \frac{|\Delta\%_{\text{baseline}}|}{\text{RSD}_{\text{baseline}}}$$

where RSDbaseline is the relative standard deviation of outcome during baseline period

A z-score > 2 indicates statistical significance (p < 0.05), meaning the observed change exceeds typical baseline fluctuation and is unlikely due to random variation.

Statistical Significance

Correlation significance is assessed using a two-tailed t-test:

$$t = \frac{r\sqrt{n-2}}{\sqrt{1-r^2}}$$

We reject the null hypothesis (ρ = 0) at α = 0.05 when |t| exceeds the critical value, providing statistical evidence that the observed relationship is not due to chance.

Data Sources

Pride data was primarily collected using QuantiModo. QuantiModo allows you to easily track mood, symptoms, or any outcome you want to optimize in a fraction of a second. You can also import your data from over 30 other apps and devices. QuantiModo then analyzes your data to identify which hidden factors are most likely to be influencing your mood or symptoms.

Insomnia data was primarily collected using QuantiModo. QuantiModo allows you to easily track mood, symptoms, or any outcome you want to optimize in a fraction of a second. You can also import your data from over 30 other apps and devices. QuantiModo then analyzes your data to identify which hidden factors are most likely to be influencing your mood or symptoms.

Data Quality

Data quality measures were applied to ensure reliable results:

  • Minimum Data Requirement: Only participants with sufficient paired observations were included in the analysis.
  • Outlier Handling: Extreme values were winsorized to reduce the influence of measurement errors.
  • Missing Data: Days with missing values were handled using appropriate filling strategies based on the variable type.
  • Test User Exclusion: Test accounts and invalid users were excluded from all analyses.

Principal Investigator

Program & Methods

Mike P. Sinn
Sinn, M. P.

Designed and implemented data collection, aggregation, causal inference pipeline, and automated study generation framework. Developed the Predictor Impact Score methodology operationalizing Bradford Hill criteria for ranking causal relationships in observational data. When he tells people this at parties, they usually say they have to go check on their car.

Individual study outputs are automated, reproducible, and open to external audit. (Which I would seriously recommend.)

Contact

Cite This Study

APA Format
Sinn, M. P. (2026). Causal Analysis: Does Pride Affect Insomnia (h)?. The Journal of Citizen Science. https://studies.crowdsourcingcures.org/study/cause-1411-effect-1462811-population-study
BibTeX 
@misc{sinn_cause_1411_effect_1462811_population_study_2026,
  author = {Sinn, Mike P.},
  title = {Causal Analysis: Does Pride Affect Insomnia (h)?},
  year = {2026},
  publisher = {The Journal of Citizen Science},
  url = {https://studies.crowdsourcingcures.org/study/cause-1411-effect-1462811-population-study},
  note = {Accessed: January 10, 2026}
}
Chicago/Turabian
Sinn, Mike P. "Causal Analysis: Does Pride Affect Insomnia (h)?." The Journal of Citizen Science. Accessed January 10, 2026. https://studies.crowdsourcingcures.org/study/cause-1411-effect-1462811-population-study.
Harvard
Sinn, M.P., 2026. Causal Analysis: Does Pride Affect Insomnia (h)?. [Aggregated N-of-1 Study] The Journal of Citizen Science. Available at: https://studies.crowdsourcingcures.org/study/cause-1411-effect-1462811-population-study [Accessed January 10, 2026].

Study Type: Aggregated N-of-1 Observational Mega-Study
Evidence Level: Level II (Real-World Evidence)
Methodology: Bradford Hill Criteria with Predictor Impact Score (PIS)

References

This framework was originally developed in 2013 based on the Bradford Hill criteria. Subsequent literature has independently validated similar approaches to causal inference from observational data:

  1. Hill, A.B. (1965). The environment and disease: association or causation? Proceedings of the Royal Society of Medicine, 58(5), 295-300. [Bradford Hill criteria]
  2. Lillie, E.O., et al. (2011). The n-of-1 clinical trial: the ultimate strategy for individualizing medicine? Personalized Medicine, 8(2), 161-173. [N-of-1 methodology]
  3. Pearl, J. (2009). Causality: Models, Reasoning, and Inference . Cambridge University Press. [Causal inference]
  4. Hernán, M.A., & Robins, J.M. (2020). Causal Inference: What If . Chapman & Hall/CRC. [Free textbook]
  5. FDA (2018). Framework for FDA's Real-World Evidence Program . U.S. Food and Drug Administration. [Regulatory context]
  6. Duan, N., et al. (2013). Single-patient (n-of-1) trials: a pragmatic clinical decision methodology . Journal of Clinical Epidemiology, 66(8), S21-S28.
  7. Platt, R., et al. (2018). The FDA Sentinel Initiative—an evolving national resource . New England Journal of Medicine, 379(22), 2091-2093.

This information is for research and educational purposes only, not medical advice. Consult a healthcare provider before making health decisions. Terms of Service

LinkedIn Reddit